TOKYO —

New details are emerging surrounding the passing of Presley Gerber, the 27-year-old model and son of supermodel Cindy Crawford, as authorities continue their investigation into the circumstances of his death at a California rehabilitation center. The Santa Monica Police Department confirmed that officers responded to a report of a possible overdose at approximately 9:35 AM on September 20th, where they discovered an adult male, later identified as Gerber, deceased.

The investigation is currently proceeding as a potential overdose, with law enforcement indicating no immediate signs of criminal involvement. The Los Angeles County Department of Medical Examiner-Coroner has completed an autopsy, but the official cause and manner of death remain pending further studies, including comprehensive toxicological analyses.

Amidst this ongoing official inquiry, a significant detail regarding a treatment Gerber received several months prior to his death has come to light. This information, which Gerber himself publicly shared, involves the use of ibogaine, a psychoactive substance.

Journey to Mexico for Ibogaine Treatment

Approximately six months before his passing, in March, Presley Gerber traveled to Cancun, Mexico, to undergo a treatment regimen involving ibogaine. At the time, the model shared a video documenting aspects of his preparation for the procedure, referring to it as an "Ibogaine Flood Dose." In his public statements, Gerber candidly discussed the apprehension he felt before embarking on this experience and his commitment to the process as part of his recovery journey.

Reports of Gerber’s ibogaine treatment have been noted by international media outlets, including The Independent and HOLA. However, experts emphasize that this antecedent does not establish a direct causal link to his death. Dr. Antón Gómez-Escolar, a psychopharmacologist and specialist in psychedelics at the Inawe Foundation, stated to HOLA, "His death cannot be linked to ibogaine. He underwent this treatment months ago." This perspective highlights the temporal distance between the treatment and Gerber’s passing, suggesting that other factors are more likely to be relevant to the ongoing investigation.

Understanding Ibogaine: Nature, Use, and Scientific Interest

Ibogaine is a naturally occurring psychoactive substance derived from the root bark of the Tabernanthe iboga plant, indigenous to Central Africa. Its potential therapeutic applications for substance use disorders, particularly in cases of opioid and alcohol dependence, have garnered considerable scientific interest. This interest stems from preliminary research suggesting that ibogaine may interrupt withdrawal symptoms and cravings, and potentially address the underlying neurological pathways associated with addiction.

Historically, ibogaine has been used in traditional West African spiritual ceremonies. In the late 20th century, it began to gain traction in Western alternative medicine circles as a treatment for addiction. The substance is known to induce intense visionary and introspective experiences, often described as a profound journey into one’s subconscious. Proponents of ibogaine therapy suggest that these experiences can lead to significant psychological breakthroughs, enabling individuals to confront and process the root causes of their addictive behaviors.

However, it is crucial to understand that ibogaine treatment is considered experimental. While promising in some respects, its efficacy and safety are still subjects of ongoing research. More extensive and rigorously controlled studies are required to definitively establish its long-term effectiveness and potential risks. In many Western countries, including the United States, ibogaine is not approved as a mainstream medical treatment. Its use is often confined to specialized clinics, predominantly in countries where it is more accessible or less regulated, such as Mexico and certain parts of Europe.

The Risks and Medical Considerations of Ibogaine Treatment

Despite its potential therapeutic promise, ibogaine is associated with significant risks, particularly concerning the cardiovascular system. The substance has been known to prolong the QT interval in electrocardiograms (ECGs), a measure of the time it takes for the heart’s ventricles to electrically recharge after each beat. This prolongation can disrupt the heart’s normal rhythm, increasing the risk of potentially life-threatening arrhythmias, such as Torsades de Pointes.

Consequently, any supervised administration of ibogaine necessitates a comprehensive medical evaluation. This typically includes a thorough cardiovascular assessment, including ECGs and potentially Holter monitoring, along with baseline laboratory tests. Physicians also review a patient’s medical history, including any pre-existing heart conditions and concurrent medications that could interact with ibogaine or exacerbate cardiovascular risks. During and after administration, continuous monitoring of vital signs and cardiac activity is paramount.

Ibogaine is usually administered orally, and the intense psychoactive experience can last for several hours, often accompanied by periods of significant physical and emotional introspection. The supervised setting is designed to provide a safe environment for the patient to navigate these profound effects, with medical and psychological support readily available. The complexity of these risks underscores why ibogaine is typically administered in specialized, controlled environments with experienced medical professionals.

Gerber’s Public Stance on Recovery and Mental Health Advocacy

Presley Gerber’s decision to undergo ibogaine treatment was part of a broader, publicly acknowledged commitment to his personal recovery and mental well-being. Over the past few years, Gerber had been vocal about his struggles with addiction and mental health challenges. This openness aimed not only to process his own experiences but also to offer support and solidarity to others facing similar battles.

In 2023, during an appearance on the podcast "Studio 22," Gerber described his recovery as a continuous, demanding effort, stating it was "a 24-hour-a-day, seven-days-a-week job." He expressed his belief that sharing his journey could serve as a source of inspiration and understanding for others. This commitment extended to his creation of "Mental Health Mondays" on social media, a platform where he discussed various aspects of mental health, aiming to destigmatize these conversations and foster a supportive online community.

His public dialogue about addiction and recovery reflects a growing trend among public figures to use their platforms to advocate for mental health awareness. By sharing his vulnerabilities, Gerber sought to contribute to a more open and compassionate discourse around these often-stigmatized issues. This aspect of his life underscores a desire to move beyond personal struggles and contribute positively to societal understanding and support systems for mental health.

The Official Investigation and Family’s Plea for Privacy

The ongoing investigation into Presley Gerber’s death is awaiting the final forensic results, which are expected to provide a definitive determination of the cause and manner of his passing. Until these official reports are released, speculation regarding contributing factors remains unofficial.

Following his death, the Gerber family issued a statement requesting privacy during this profoundly difficult time. Cindy Crawford and Rande Gerber, along with their daughter Kaia Gerber, have expressed their deep grief and asked the public and media to respect their need for space as they mourn their loss. This plea for privacy is a standard request in such circumstances, allowing families the necessary time and space to cope with tragedy without undue external pressure.

The circumstances surrounding the death of a young public figure like Presley Gerber inevitably draw significant media attention. However, the focus remains on the official investigation and the family’s need for solace. The details surrounding his ibogaine treatment, while notable, serve as one piece of information within a larger, ongoing inquiry. The ultimate findings of the medical examiner’s office will be crucial in providing clarity and closure to this tragic event. The broader implications of his story may lie in the continued conversation about addiction, mental health, and the complex landscape of experimental treatments, underscoring the need for both hope and caution.